Clinical Trial Update: Evaluate Pharmacokinetics and Safety of Slow Release DHEA [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the pharmacokinetics and safety of a slow-release formulation of dehydroepiandrosterone (DHEA) in individuals wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DHEA slow-release (dehydroepiandrosterone)

Snippet

Sponsor: Indiana University | Conditions: Asthma, Genotype | Phase 1, Phase 2 | Status: COMPLETED